{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:10:50Z","timestamp":1788275450015,"version":"build-2803163510"},"reference-count":56,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical Science Research Project of Hebei","award":["No. 20240360"],"award-info":[{"award-number":["No. 20240360"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>\n                    Renal carcinoma ranks among the most lethal cancers, primarily attributed to its atypical symptoms and high metastatic potential. The metabolism of nicotinamide (NAM) plays a significant role in the progression of various tumors. However, investigations into the impact of the NAM metabolism-related signature (NMRS) in kidney renal clear cell carcinoma (KIRC) remain insufficient. Clinical and RNA sequencing data (RNA-seq) from 541 KIRC tissues and 72 adjacent normal tissues were extracted from TCGA. NAM metabolism-related genes (NMRGs) were identified through the Molecular Signatures Database. Cox regression analyses (univariate\/multivariate) were conducted to develop NMRS. Time-dependent ROC curve analysis showed that this method had good accuracy in predicting 1-year (AUC = 0.691), 3-year (AUC = 0.749), and 5-year (AUC = 0.764) survival. The Receiver Operating Characteristic (ROC) curve from the external RECA-EU dataset (AUC = 0.682) highlights the accurate prognostic assessment of the NMRS. Overall survival (OS) rates across distinct risk groups were compared using KM analysis. The Cox proportional hazards model assessed the influence of clinicopathological factors and risk scores on survival outcomes (HR = 1.437, 95% CI [1.232\u20131.676];\n                    <jats:italic>P<\/jats:italic>\n                    &lt;\u00a00.001). Evaluation of the immune microenvironment employed the ESTIMATE and CIBERSORT methods, while enrichment analysis examined biological significance. Correlation analysis determined the link between the expression of checkpoint genes and risk scores. StarBase and miRTarBase facilitated the prediction of target miRNAs and lncRNAs bindingto NMRGs. This study presents a novel framework for identifying prognostic biomarkers and therapeutic targets in KIRC.\n                  <\/jats:p>","DOI":"10.7717\/peerj.21300","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T08:32:27Z","timestamp":1780993947000},"page":"e21300","source":"Crossref","is-referenced-by-count":1,"title":["Nicotinamide metabolism-related signature and lncRNA regulatory network in kidney renal clear cell carcinoma"],"prefix":"10.7717","volume":"14","author":[{"given":"Pei","family":"Dong","sequence":"first","affiliation":[{"name":"The Fourth Hospital of Hebei Medical University, State Grid Hebei Information & Telecommunication Company, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lincong","family":"Zhao","sequence":"additional","affiliation":[{"name":"The Fourth Hospital of Hebei Medical University, State Grid Hebei Information & Telecommunication Company, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyao","family":"Shi","sequence":"additional","affiliation":[{"name":"The Fourth Hospital of Hebei Medical University, State Grid Hebei Information & Telecommunication Company, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Ma","sequence":"additional","affiliation":[{"name":"The Fourth Hospital of Hebei Medical University, State Grid Hebei Information & Telecommunication Company, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beixuan","family":"Huang","sequence":"additional","affiliation":[{"name":"The Fourth Hospital of Hebei Medical University, State Grid Hebei Information & Telecommunication Company, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenda","family":"Wang","sequence":"additional","affiliation":[{"name":"The Fourth Hospital of Hebei Medical University, State Grid Hebei Information & Telecommunication Company, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowei","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Fourth Hospital of Hebei Medical University, State Grid Hebei Information & Telecommunication Company, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[{"name":"The Fourth Hospital of Hebei Medical University, State Grid Hebei Information & Telecommunication Company, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4443","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"10.7717\/peerj.21300\/ref-1","doi-asserted-by":"publisher","first-page":"101195","DOI":"10.1016\/j.molmet.2021.101195","article-title":"Role of NAD(+) in regulating cellular and metabolic signaling pathways","volume":"49","author":"Amjad","year":"2021","journal-title":"Molecular Metabolism"},{"issue":"5","key":"10.7717\/peerj.21300\/ref-2","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.3390\/jcm9051594","article-title":"Anti-angiogenesis and immunotherapy: novel paradigms to envision tailored approaches in renal cell-carcinoma","volume":"9","author":"Argentiero","year":"2020","journal-title":"Journal of Clinical Medicine"},{"issue":"13","key":"10.7717\/peerj.21300\/ref-3","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.1158\/0008-5472.CAN-10-4452","article-title":"Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53\/miR-34a\/SIRT1 tumor suppressor network","volume":"71","author":"Audrito","year":"2011","journal-title":"Cancer Research"},{"issue":"30","key":"10.7717\/peerj.21300\/ref-4","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Statistics in Medicine"},{"issue":"13","key":"10.7717\/peerj.21300\/ref-5","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.2174\/092986711795590101","article-title":"NAMPT in regulated NAD biosynthesis and its pivotal role in human metabolism","volume":"18","author":"Burgos","year":"2011","journal-title":"Current Medicinal Chemistry"},{"issue":"8","key":"10.7717\/peerj.21300\/ref-6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"issue":"17","key":"10.7717\/peerj.21300\/ref-7","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","article-title":"A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention","volume":"373","author":"Chen","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.7717\/peerj.21300\/ref-8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","article-title":"NAD(+) metabolism and its roles in cellular processes during ageing","volume":"22","author":"Covarrubias","year":"2021","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"6","key":"10.7717\/peerj.21300\/ref-9","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1096\/fasebj.13.6.657","article-title":"Neural cell surface differentiation antigen gp130(RB13-6) induces fibroblasts and glioma cells to express astroglial proteins and invasive properties","volume":"13","author":"Deissler","year":"1999","journal-title":"FASEB Journal"},{"issue":"3","key":"10.7717\/peerj.21300\/ref-10","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s42255-023-00761-7","article-title":"NAD(+) precursor supplementation prevents mtRNA\/RIG-I-dependent inflammation during kidney injury","volume":"5","author":"Doke","year":"2023","journal-title":"Nature Metabolism"},{"issue":"8","key":"10.7717\/peerj.21300\/ref-11","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1158\/1078-0432.CCR-15-1542","article-title":"AGS16F is a novel antibody drug conjugate directed against ENPP3 for the treatment of renal cell carcinoma","volume":"22","author":"Donate","year":"2016","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10.7717\/peerj.21300\/ref-12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.21037\/tcr-23-214","article-title":"A model based on immunogenic cell death-related genes predicts prognosis and response to immunotherapy in kidney renal clear cell carcinoma","volume":"13","author":"Dong","year":"2024","journal-title":"Translational Cancer Research"},{"issue":"1","key":"10.7717\/peerj.21300\/ref-13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/ndt\/gfaa124","article-title":"Differential role of nicotinamide adenine dinucleotide deficiency in acute and chronic kidney disease","volume":"36","author":"Faivre","year":"2021","journal-title":"Nephrology, Dialysis, Transplantation"},{"issue":"9","key":"10.7717\/peerj.21300\/ref-14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrendo.2015.117","article-title":"Physiological and pathophysiological roles of NAMPT and NAD metabolism","volume":"11","author":"Garten","year":"2015","journal-title":"Nature Reviews Endocrinology"},{"issue":"8","key":"10.7717\/peerj.21300\/ref-15","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1681\/ASN.2016040385","article-title":"Nicotinamide mononucleotide, an NAD(+) precursor, rescues age-associated susceptibility to AKI in a sirtuin 1-dependent manner","volume":"28","author":"Guan","year":"2017","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.7717\/peerj.21300\/ref-16","doi-asserted-by":"publisher","first-page":"13712","DOI":"10.1038\/s41598-022-18147-2","article-title":"Nicotinamide mononucleotide ameliorates adriamycin-induced renal damage by epigenetically suppressing the NMN\/NAD consumers mediated by Twist2","volume":"12","author":"Hasegawa","year":"2022","journal-title":"Scientific Reports"},{"issue":"1","key":"10.7717\/peerj.21300\/ref-17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s13046-022-02543-7","article-title":"A novel lncRNA MDHDH suppresses glioblastoma multiforme by acting as a scaffold for MDH2 and PSMA1 to regulate NAD+ metabolism and autophagy","volume":"41","author":"He","year":"2022","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"6431","key":"10.7717\/peerj.21300\/ref-18","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1126\/science.aau3903","article-title":"Direct stimulation of NADP(+) synthesis through Akt-mediated phosphorylation of NAD kinase","volume":"363","author":"Hoxhaj","year":"2019","journal-title":"Science"},{"issue":"18","key":"10.7717\/peerj.21300\/ref-19","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1007\/s00018-017-2527-8","article-title":"Nicotinamide is an inhibitor of SIRT1 in vitro, but can be a stimulator in cells","volume":"74","author":"Hwang","year":"2017","journal-title":"Cellular and Molecular Life Science"},{"issue":"2","key":"10.7717\/peerj.21300\/ref-20","doi-asserted-by":"publisher","first-page":"e57160","DOI":"10.1371\/journal.pone.0057160","article-title":"Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanoma","volume":"8","author":"Itzhaki","year":"2013","journal-title":"PLOS ONE"},{"key":"10.7717\/peerj.21300\/ref-21","doi-asserted-by":"publisher","first-page":"649547","DOI":"10.3389\/fphys.2021.649547","article-title":"Nicotinamide mononucleotide attenuates renal interstitial fibrosis after AKI by suppressing tubular DNA damage and senescence","volume":"12","author":"Jia","year":"2021","journal-title":"Frontiers in Physiology"},{"issue":"9","key":"10.7717\/peerj.21300\/ref-22","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1002\/1878-0261.13209","article-title":"Nicotinamide (niacin) supplement increases lipid metabolism and ROS-induced energy disruption in triple-negative breast cancer: potential for drug repositioning as an anti-tumor agent","volume":"16","author":"Jung","year":"2022","journal-title":"Molecular Oncology"},{"issue":"12","key":"10.7717\/peerj.21300\/ref-23","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S1470-2045(02)00929-4","article-title":"ARCON: a novel biology-based approach in radiotherapy","volume":"3","author":"Kaanders","year":"2002","journal-title":"The Lancet Oncology"},{"issue":"1","key":"10.7717\/peerj.21300\/ref-24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3390\/toxins13010050","article-title":"Nicotinamide attenuates the progression of renal failure in a mouse model of adenine-induced chronic kidney disease","volume":"13","author":"Kumakura","year":"2021","journal-title":"Toxins"},{"key":"10.7717\/peerj.21300\/ref-25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/1471-2407-11-133","article-title":"Renal cell cancer among African Americans: an epidemiologic review","volume":"11","author":"Lipworth","year":"2011","journal-title":"BMC Cancer"},{"issue":"2","key":"10.7717\/peerj.21300\/ref-26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0092-8674(01)00524-4","article-title":"Negative control of p53 by Sir2alpha promotes cell survival under stress","volume":"107","author":"Luo","year":"2001","journal-title":"Cell"},{"issue":"6","key":"10.7717\/peerj.21300\/ref-27","doi-asserted-by":"publisher","first-page":"e0252554","DOI":"10.1371\/journal.pone.0252554","article-title":"Effect of NAD+ boosting on kidney ischemia-reperfusion injury","volume":"16","author":"Morevati","year":"2021","journal-title":"PLOS ONE"},{"issue":"1","key":"10.7717\/peerj.21300\/ref-28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.celrep.2019.03.024","article-title":"Role of NAMPT-Sirt6 axis in renal proximal tubules in extracellular matrix deposition in diabetic nephropathy","volume":"27","author":"Muraoka","year":"2019","journal-title":"Cell Reports"},{"issue":"8","key":"10.7717\/peerj.21300\/ref-29","doi-asserted-by":"publisher","first-page":"104975","DOI":"10.1016\/j.jbc.2023.104975","article-title":"NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease","volume":"299","author":"Myakala","year":"2023","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"10.7717\/peerj.21300\/ref-30","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/ki.2013.330","article-title":"Pharmacological activation of NQO1 increases NAD(+) levels and attenuates cisplatin-mediated acute kidney injury in mice","volume":"85","author":"Oh","year":"2014","journal-title":"Kidney International"},{"issue":"3","key":"10.7717\/peerj.21300\/ref-31","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/jcp.22799","article-title":"Nicotinamide inhibits the early stage of carcinogen-induced hepatocarcinogenesis in mice and suppresses human hepatocellular carcinoma cell growth","volume":"227","author":"Park","year":"2012","journal-title":"Journal of Cellular Physiology"},{"issue":"9","key":"10.7717\/peerj.21300\/ref-32","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41591-018-0138-z","article-title":"De novo NAD(+) biosynthetic impairment in acute kidney injury in humans","volume":"24","author":"Poyan\u00a0Mehr","year":"2018","journal-title":"Nature Medicine"},{"issue":"14","key":"10.7717\/peerj.21300\/ref-33","doi-asserted-by":"publisher","first-page":"18812","DOI":"10.18632\/oncotarget.7712","article-title":"PARP6 acts as a tumor suppressor via downregulating Survivin expression in colorectal cancer","volume":"7","author":"Qi","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.7717\/peerj.21300\/ref-34","doi-asserted-by":"publisher","first-page":"848","DOI":"10.17305\/bb.2023.9989","article-title":"Hypomethylation of the ENPP3 promoter region contributes to the occurrence and development of ovarian endometriosis via the AKT\/mTOR\/4EBP1 signaling pathway","volume":"24","author":"Qin","year":"2023","journal-title":"Biomolecules and Biomedicine"},{"issue":"1","key":"10.7717\/peerj.21300\/ref-35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.34067\/KID.0006452020","article-title":"Niacinamide may be associated with improved outcomes in COVID-19-related acute kidney injury: an observational study","volume":"2","author":"Raines","year":"2021","journal-title":"Kidney360"},{"issue":"2","key":"10.7717\/peerj.21300\/ref-36","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3181\/00379727-151-39209","article-title":"Modification of renal tumorigenic effect of streptozotocin by nicotinamide: spontaneous reversibility of streptozotocin diabetes","volume":"151","author":"Rakieten","year":"1976","journal-title":"Proceedings of the Society for Experimental Biology and Medicine"},{"issue":"2","key":"10.7717\/peerj.21300\/ref-37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41581-019-0216-6","article-title":"NAD(+) homeostasis in renal health and disease","volume":"16","author":"Ralto","year":"2020","journal-title":"Nature Reviews Nephrology"},{"issue":"2","key":"10.7717\/peerj.21300\/ref-38","first-page":"809","article-title":"Promoting effect of nicotinamide on the development of renal tubular cell tumors in rats initiated with diethylnitrosamine","volume":"45","author":"Rosenberg","year":"1985","journal-title":"Cancer Research"},{"issue":"10","key":"10.7717\/peerj.21300\/ref-39","doi-asserted-by":"publisher","first-page":"7859","DOI":"10.1007\/s13277-015-3506-z","article-title":"Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin\/survivin DEx3 expression","volume":"36","author":"Sawicka-Gutaj","year":"2015","journal-title":"Tumour Biology"},{"issue":"11\u201312","key":"10.7717\/peerj.21300\/ref-40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/1947601913507576","article-title":"Nicotinamide phosphoribosyltransferase in malignancy: a review","volume":"4","author":"Shackelford","year":"2013","journal-title":"Genes Cancer"},{"issue":"30","key":"10.7717\/peerj.21300\/ref-41","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1126\/sciadv.abf3895","article-title":"Nuclear NAD(+) homeostasis governed by NMNAT1 prevents apoptosis of acute myeloid leukemia stem cells","volume":"7","author":"Shi","year":"2021","journal-title":"Science Advances"},{"key":"10.7717\/peerj.21300\/ref-42","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ejmech.2017.08.007","article-title":"Recent developments in small molecule therapies for renal cell carcinoma","volume":"142","author":"Song","year":"2017","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"10","key":"10.7717\/peerj.21300\/ref-43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11306-019-1604-4","article-title":"Diverse therapeutic efficacies and more diverse mechanisms of nicotinamide","volume":"15","author":"Song","year":"2019","journal-title":"Metabolomics"},{"key":"10.7717\/peerj.21300\/ref-44","doi-asserted-by":"publisher","first-page":"157591","DOI":"10.4061\/2010\/157591","article-title":"Role of nicotinamide in DNA damage, mutagenesis, and DNA repair","volume":"2010","author":"Surjana","year":"2010","journal-title":"Journal of Nucleic Acids"},{"issue":"1093","key":"10.7717\/peerj.21300\/ref-45","doi-asserted-by":"publisher","first-page":"20170966","DOI":"10.1259\/bjr.20170966","article-title":"Clinical trials targeting hypoxia","volume":"92","author":"Tharmalingham","year":"2019","journal-title":"British Journal of Radiology"},{"issue":"7595","key":"10.7717\/peerj.21300\/ref-46","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nature17184","article-title":"PGC1alpha drives NAD biosynthesis linking oxidative metabolism to renal protection","volume":"531","author":"Tran","year":"2016","journal-title":"Nature"},{"issue":"8","key":"10.7717\/peerj.21300\/ref-47","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1158\/0008-5472.CAN-18-1544","article-title":"Nicotinamide phosphoribosyltransferase acts as a metabolic gate for mobilization of myeloid-derived suppressor cells","volume":"79","author":"Travelli","year":"2019","journal-title":"Cancer Research"},{"issue":"6","key":"10.7717\/peerj.21300\/ref-48","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.3892\/ijo.2012.1652","article-title":"PARP6, a mono(ADP-ribosyl) transferase and a negative regulator of cell proliferation, is involved in colorectal cancer development","volume":"41","author":"Tuncel","year":"2012","journal-title":"International Journal of Oncology"},{"issue":"10","key":"10.7717\/peerj.21300\/ref-49","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Valdes-Tresanco","year":"2021","journal-title":"Journal of Chemical Theory and Computation"},{"issue":"6265","key":"10.7717\/peerj.21300\/ref-50","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.aac4854","article-title":"NAD(+) in aging, metabolism, and neurodegeneration","volume":"350","author":"Verdin","year":"2015","journal-title":"Science"},{"issue":"2","key":"10.7717\/peerj.21300\/ref-51","first-page":"503","article-title":"Increased nicotinamide phosphoribosyltransferase in rhabdomyosarcomas and leiomyosarcomas compared to skeletal and smooth muscle tissue","volume":"36","author":"Vora","year":"2016","journal-title":"Anticancer Research"},{"issue":"7","key":"10.7717\/peerj.21300\/ref-52","doi-asserted-by":"publisher","first-page":"1596715","DOI":"10.1080\/2162402X.2019.1596715","article-title":"Development and validation of an immune-related gene pairs signature in colorectal cancer","volume":"8","author":"Wu","year":"2019","journal-title":"Oncoimmunology"},{"issue":"10","key":"10.7717\/peerj.21300\/ref-53","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1681\/ASN.2021071000","article-title":"Correction: pre-emptive short-term nicotinamide mononucleotide treatment in a mouse model of diabetic nephropathy","volume":"32","author":"Yasuda","year":"2021","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.7717\/peerj.21300\/ref-54","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1681\/ASN.2020081188","article-title":"Pre-emptive short-term nicotinamide mononucleotide treatment in a mouse model of diabetic nephropathy","volume":"32","author":"Yasuda","year":"2021","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.7717\/peerj.21300\/ref-55","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10147-015-0894-4","article-title":"Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with metastatic renal cell carcinoma receiving targeted therapy","volume":"21","author":"Zhang","year":"2016","journal-title":"International Journal of Clinical Oncology"},{"key":"10.7717\/peerj.21300\/ref-56","doi-asserted-by":"publisher","first-page":"909123","DOI":"10.3389\/fphar.2022.909123","article-title":"Endoplasmic reticulum stress-related signature predicts prognosis and drug response in clear cell renal cell carcinoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Frontiers in Pharmacology"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/21300.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/21300.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/21300.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/21300.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T08:32:35Z","timestamp":1780993955000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/21300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":56,"alternative-id":["10.7717\/peerj.21300"],"URL":"https:\/\/doi.org\/10.7717\/peerj.21300","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"article-number":"e21300"}}